Comprehensive Risk Stratification of Japanese Patients With Aortic Stenosis – A Proposal of a New Risk Score From the CHART-2 Study
Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Stu...
Saved in:
Published in: | Circulation Journal Vol. 79; no. 7; pp. 1631 - 1638 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Japan
The Japanese Circulation Society
2015
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III–IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.Conclusions:The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. (Circ J 2015; 79: 1631–1638) |
---|---|
AbstractList | The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.
We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III-IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.
The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III–IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.Conclusions:The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. (Circ J 2015; 79: 1631–1638) BACKGROUNDThe risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.METHODS AND RESULTSWe aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III-IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.CONCLUSIONSThe present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. |
Author | Nochioka, Kotaro Sato, Kenjiro Sakata, Yasuhiko Onose, Takeo Miyata, Satoshi Abe, Ruri Shimokawa, Hiroaki Takahashi, Jun Tadaki, Soichiro Miura, Masanobu Tsuji, Kanako on behalf of the CHART-2 Investigators Yamauchi, Takeshi Ushigome, Ryoichi |
Author_xml | – sequence: 1 fullname: Sato, Kenjiro organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 2 fullname: Sakata, Yasuhiko organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 3 fullname: Miura, Masanobu organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 4 fullname: Tadaki, Soichiro organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 5 fullname: Ushigome, Ryoichi organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 6 fullname: Yamauchi, Takeshi organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 7 fullname: Onose, Takeo organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 8 fullname: Tsuji, Kanako organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 9 fullname: Abe, Ruri organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 10 fullname: Nochioka, Kotaro organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 11 fullname: Takahashi, Jun organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 12 fullname: Miyata, Satoshi organization: Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 13 fullname: Shimokawa, Hiroaki organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine – sequence: 14 fullname: on behalf of the CHART-2 Investigators |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25947000$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkMtO3DAUhq2KqlzafVfIy25CfcvFy1HUgY4QIErVpWWcE8bTJE5tDxW72fEAvGH7InWYKcjSsWV9_y-d7xDtDW4AhD5SckJZzj8b683qpF5kNM8IKdgbdEC5KDNRMbL3_C4yWQm-jw5DWBHCJMnlO7TPcilKQsgBeqxdP3pYwhDsPeBrG37ib9HraFtr0nQDdi1e6FEPEABfpS8YYsA_bFzimfPRmsTD4IINfzebP5snPMNX3o0u6G6KanwBv3e9xnnAc-96HJeA67PZ9U3GUnzdPLxHb1vdBfiwu4_Q9_mXm_osO788_VrPzjMjpIhZQU3TgmmB8duGG2qIZMBYyRoqqjydFrQkRcV1qStRFFRzbdqG5jwxnHF-hD5te0fvfq0hRNXbYKDr0n5uHRQtJGNSMMESSrao8S4ED60ave21f1CUqEm_etav6oWiuZr0p8jxrn1920PzEvjvOwHzLbAKUd_BC6AnkR3sGkupymm8Nr8CS-0VDPwfybGeWA |
CitedBy_id | crossref_primary_10_1016_j_jjcc_2016_10_018 crossref_primary_10_1093_eurjpc_zwae086 crossref_primary_10_1253_circj_CJ_16_0636 crossref_primary_10_1253_circj_CJ_15_0578 crossref_primary_10_1002_ejhf_405 |
Cites_doi | 10.1016/j.jacc.2012.08.988 10.1161/CIR.0b013e31829e8776 10.1016/j.jacc.2009.04.079 10.1161/01.CIR.101.7.765 10.1253/circj.CJ-11-0135 10.1161/CIRCULATIONAHA.108.808857 10.1016/S0140-6736(06)69208-8 10.1016/j.amjcard.2004.05.055 10.1161/CIRCULATIONAHA.105.584102 10.1253/circj.CJ-12-0025 10.1016/j.jcmg.2009.11.019 10.1161/01.CIR.38.1S5.V-61 10.1016/0735-1097(90)90234-G 10.1161/CIRCULATIONAHA.109.909903 10.1016/j.jacc.2006.05.021 10.1253/circj.72.1265 10.1067/mhj.2001.117131 10.1016/j.jtcvs.2007.08.058 10.1253/circj.CJ-13-0127 10.1161/CIRCHEARTFAILURE.111.965020 10.1136/hrt.82.2.143 10.1093/eurheartj/ehs337 10.1016/0002-8703(80)90375-0 10.1056/NEJM200008313430903 10.1253/circj.CJ-11-0012 10.1253/circj.CJ-13-1009 10.1016/j.athoracsur.2006.07.048 10.1016/j.amjcard.2012.10.015 10.1161/CIRCULATIONAHA.104.495903 10.1253/circj.CJ-14-0162 |
ContentType | Journal Article |
Contributor | Yahagi, Hirokazu Tamada, Yoshiaki Koyama, Jiro Takeuchi, Masaharu Sato, Kimio Akai, Kenjiro Fukui, Shigefumi Katoh, Atsushi Oyama, Shigeto Endo, Hideaki Suzuki, Shu Fushimi, Etsuko Takahashi, Nozomu Shinozaki, Tsuyoshi Fukahori, Kouhei Takahashi, Kikuyo Ogata, Masahiko Sugai, Yoshinao Kikuchi, Yoku Nakagawa, Makoto Yagi, Takuya Nozaki, Eiji Nozaki, Tetsuji Matsui, Motoyuki Nakayama, Masaharu Goto, Toshikazu Kanno, Hiroyuki Fukuda, Koji Nakano, Makoto Komatsu, Seiji Ishizuka, Takeshi Takahashi, Tohru Chida, Masanobu Ohe, Masatoshi Ohashi, Junko Ito, Yoshitaka Sugimura, Akihiko Ito, Kenta Matsumoto, Yasuharu Kawana, Akiko Tanikawa, Toshinori Yahagi, Tomoyasu Tashima, Takurou Saji, Kenya Shimokawa, Hiroaki Fukui, Akio Fujita, Hiroshi Kaneko, Junji Aizawa, Kentaro Tsuburaya, Ryuji Kobayashi, Tadashi Onodera, Sachio Kato, Atsushi Sugie, Tadashi Hiramoto, Tetsuya Horiguchi, Satoru Nochioka, Kotaro Katayose, Dai Morita, Masaki Sakata, Yasuhiko Takeda, Satoru Iwabuchi, Kaoru Koseki, Yoshito Kato, Hiroshi Nakajima, Sota Sato, Shoichi Sugimura, Koichiro Nakamur |
Contributor_xml | – sequence: 1 givenname: Hiroaki surname: Shimokawa fullname: Shimokawa, Hiroaki – sequence: 2 givenname: Toshikazu surname: Goto fullname: Goto, Toshikazu – sequence: 3 givenname: Eiji surname: Nozaki fullname: Nozaki, Eiji – sequence: 4 givenname: Tetsuya surname: Hiramoto fullname: Hiramoto, Tetsuya – sequence: 5 givenname: Mitsumasa surname: Fukuchi fullname: Fukuchi, Mitsumasa – sequence: 6 givenname: Kanichi surname: Inoue fullname: Inoue, Kanichi – sequence: 7 givenname: Atsushi surname: Kato fullname: Kato, Atsushi – sequence: 8 givenname: Masafumi surname: Sugi fullname: Sugi, Masafumi – sequence: 9 givenname: Masatoshi surname: Ohe fullname: Ohe, Masatoshi – sequence: 10 givenname: Tsuyoshi surname: Shinozaki fullname: Shinozaki, Tsuyoshi – sequence: 11 givenname: Satoru surname: Horiguchi fullname: Horiguchi, Satoru – sequence: 12 givenname: Hiroshi surname: Kato fullname: Kato, Hiroshi – sequence: 13 givenname: Masahiko surname: Ogata fullname: Ogata, Masahiko – sequence: 14 givenname: Shoichi surname: Sato fullname: Sato, Shoichi – sequence: 15 givenname: Shigeto surname: Oyama fullname: Oyama, Shigeto – sequence: 16 givenname: Akihiro surname: Nakamura fullname: Nakamura, Akihiro – sequence: 17 givenname: Tohru surname: Takahashi fullname: Takahashi, Tohru – sequence: 18 givenname: Hideaki surname: Endo fullname: Endo, Hideaki – sequence: 19 givenname: Shigefumi surname: Fukui fullname: Fukui, Shigefumi – sequence: 20 givenname: Sota surname: Nakajima fullname: Nakajima, Sota – sequence: 21 givenname: Makoto surname: Nakagawa fullname: Nakagawa, Makoto – sequence: 22 givenname: Tetsuji surname: Nozaki fullname: Nozaki, Tetsuji – sequence: 23 givenname: Takuya surname: Yagi fullname: Yagi, Takuya – sequence: 24 givenname: Etsuko surname: Fushimi fullname: Fushimi, Etsuko – sequence: 25 givenname: Yoshinao surname: Sugai fullname: Sugai, Yoshinao – sequence: 26 givenname: Satoru surname: Takeda fullname: Takeda, Satoru – sequence: 27 givenname: Kouhei surname: Fukahori fullname: Fukahori, Kouhei – sequence: 28 givenname: Kentaro surname: Aizawa fullname: Aizawa, Kentaro – sequence: 29 givenname: Takurou surname: Tashima fullname: Tashima, Takurou – sequence: 30 givenname: Katsuhiko surname: Sakurai fullname: Sakurai, Katsuhiko – sequence: 31 givenname: Tadashi surname: Kobayashi fullname: Kobayashi, Tadashi – sequence: 32 givenname: Motoyuki surname: Matsui fullname: Matsui, Motoyuki – sequence: 33 givenname: Yoshiaki surname: Tamada fullname: Tamada, Yoshiaki – sequence: 34 givenname: Tomoyasu surname: Yahagi fullname: Yahagi, Tomoyasu – sequence: 35 givenname: Akio surname: Fukui fullname: Fukui, Akio – sequence: 36 givenname: Katsuaki surname: Takahashi fullname: Takahashi, Katsuaki – sequence: 37 givenname: Yoku surname: Kikuchi fullname: Kikuchi, Yoku – sequence: 38 givenname: Akihiko surname: Sugimura fullname: Sugimura, Akihiko – sequence: 39 givenname: Junko surname: Ohashi fullname: Ohashi, Junko – sequence: 40 givenname: Hiroyuki surname: Kanno fullname: Kanno, Hiroyuki – sequence: 41 givenname: Junji surname: Kaneko fullname: Kaneko, Junji – sequence: 42 givenname: Shu surname: Suzuki fullname: Suzuki, Shu – sequence: 43 givenname: Kikuyo surname: Takahashi fullname: Takahashi, Kikuyo – sequence: 44 givenname: Kenjiro surname: Akai fullname: Akai, Kenjiro – sequence: 45 givenname: Dai surname: Katayose fullname: Katayose, Dai – sequence: 46 givenname: Sachio surname: Onodera fullname: Onodera, Sachio – sequence: 47 givenname: Seiji surname: Komatsu fullname: Komatsu, Seiji – sequence: 48 givenname: Masanobu surname: Chida fullname: Chida, Masanobu – sequence: 49 givenname: Kaoru surname: Iwabuchi fullname: Iwabuchi, Kaoru – sequence: 50 givenname: Masaharu surname: Takeuchi fullname: Takeuchi, Masaharu – sequence: 51 givenname: Hirokazu surname: Yahagi fullname: Yahagi, Hirokazu – sequence: 52 givenname: Nozomu surname: Takahashi fullname: Takahashi, Nozomu – sequence: 53 givenname: Keiji surname: Otsuka fullname: Otsuka, Keiji – sequence: 54 givenname: Yoshito surname: Koseki fullname: Koseki, Yoshito – sequence: 55 givenname: Masaki surname: Morita fullname: Morita, Masaki – sequence: 56 givenname: Takeshi surname: Ishizuka fullname: Ishizuka, Takeshi – sequence: 57 givenname: Noriko surname: Onoue fullname: Onoue, Noriko – sequence: 58 givenname: Nobuhiro surname: Yamaguchi fullname: Yamaguchi, Nobuhiro – sequence: 59 givenname: Hiroshi surname: Fujita fullname: Fujita, Hiroshi – sequence: 60 givenname: Atsushi surname: Katoh fullname: Katoh, Atsushi – sequence: 61 givenname: Shigeto surname: Namiuchi fullname: Namiuchi, Shigeto – sequence: 62 givenname: Tadashi surname: Sugie fullname: Sugie, Tadashi – sequence: 63 givenname: Kenya surname: Saji fullname: Saji, Kenya – sequence: 64 givenname: Toru surname: Takii fullname: Takii, Toru – sequence: 65 givenname: Toshinori surname: Tanikawa fullname: Tanikawa, Toshinori – sequence: 66 givenname: Osamu surname: Kitamukai fullname: Kitamukai, Osamu – sequence: 67 givenname: Yasuharu surname: Matsumoto fullname: Matsumoto, Yasuharu – sequence: 68 givenname: Jiro surname: Koyama fullname: Koyama, Jiro – sequence: 69 givenname: Tomoko surname: Tomioka fullname: Tomioka, Tomoko – sequence: 70 givenname: Hiroki surname: Shioiri fullname: Shioiri, Hiroki – sequence: 71 givenname: Yoshitaka surname: Ito fullname: Ito, Yoshitaka – sequence: 72 givenname: Chikako surname: Takahashi fullname: Takahashi, Chikako – sequence: 73 givenname: Akiko surname: Kawana fullname: Kawana, Akiko – sequence: 74 givenname: Yasuhiko surname: Sakata fullname: Sakata, Yasuhiko – sequence: 75 givenname: Kenta surname: Ito fullname: Ito, Kenta – sequence: 76 givenname: Masaharu surname: Nakayama fullname: Nakayama, Masaharu – sequence: 77 givenname: Koji surname: Fukuda fullname: Fukuda, Koji – sequence: 78 givenname: Jun surname: Takahashi fullname: Takahashi, Jun – sequence: 79 givenname: Satoshi surname: Miyata fullname: Miyata, Satoshi – sequence: 80 givenname: Koichiro surname: Sugimura fullname: Sugimura, Koichiro – sequence: 81 givenname: Kimio surname: Sato fullname: Sato, Kimio – sequence: 82 givenname: Makoto surname: Nakano fullname: Nakano, Makoto – sequence: 83 givenname: Takashi surname: Shiroto fullname: Shiroto, Takashi – sequence: 84 givenname: Ryuji surname: Tsuburaya fullname: Tsuburaya, Ryuji – sequence: 85 givenname: Kotaro surname: Nochioka fullname: Nochioka, Kotaro |
Copyright | 2015 THE JAPANESE CIRCULATION SOCIETY |
Copyright_xml | – notice: 2015 THE JAPANESE CIRCULATION SOCIETY |
CorporateAuthor | CHART-2 Investigators on behalf of the CHART-2 Investigators |
CorporateAuthor_xml | – name: CHART-2 Investigators – name: on behalf of the CHART-2 Investigators |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1253/circj.CJ-15-0062 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1347-4820 |
EndPage | 1638 |
ExternalDocumentID | 10_1253_circj_CJ_15_0062 25947000 article_circj_79_7_79_CJ_15_0062_article_char_en |
Genre | Multicenter Study Clinical Trial Research Support, Non-U.S. Gov't Journal Article Observational Study |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .55 29B 2WC 53G 5GY 5RE 6J9 AAUGY ACGFO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P GX1 JSF JSH KQ8 M~E OK1 P2P RJT RNS RZJ TR2 W2D X7M XSB ZXP .GJ 3O- CGR CUY CVF ECM EIF NPM RYR TKC AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c494t-61cdfecfe23bd3c1c092e2272d1485858fea90683a7a84661a3acfd1532723233 |
ISSN | 1346-9843 |
IngestDate | Fri Jun 28 05:09:24 EDT 2024 Fri Aug 23 02:59:05 EDT 2024 Tue Oct 15 23:53:01 EDT 2024 Thu Aug 17 20:27:09 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c494t-61cdfecfe23bd3c1c092e2272d1485858fea90683a7a84661a3acfd1532723233 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/circj/79/7/79_CJ-15-0062/_article/-char/en |
PMID | 25947000 |
PQID | 1692294242 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1692294242 crossref_primary_10_1253_circj_CJ_15_0062 pubmed_primary_25947000 jstage_primary_article_circj_79_7_79_CJ_15_0062_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2015-00-00 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – year: 2015 text: 2015-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Circulation Journal |
PublicationTitleAlternate | Circ J |
PublicationYear | 2015 |
Publisher | The Japanese Circulation Society |
Publisher_xml | – name: The Japanese Circulation Society |
References | 18. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004; 94: 740–745. 20. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle heart failure model: Prediction of survival in heart failure. Circulation 2006; 113: 1424–1433. 4. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 non-surgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111–2115. 23. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, et al; on behalf of the CHART-2 Investigators. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: A report from the CHART-2 Study. Circ J 2013; 77: 2318–2326. 16. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, Shapiro BP, et al. Indices of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). Am J Cardiol 2013; 111: 374–381. 34. Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Orszulak TA, et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2008; 135: 308–315. 24. Sakata Y, Miyata S, Nochioka K, Miura M, Takada T, Tadaki S, et al. Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C/D heart failure in Japan: Report from the CHART-2 study. Circ J 2014; 78: 2276–2283. 32. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617. 31. Pellika PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990; 15: 1012–1017. 33. Ohno M, Hashimoto Y, Suzuki M, Matsumura A, Isobe M. Current state of symptomatic aortic valve stenosis in the Japanese elderly. Circ J 2011; 75: 2474–2481. 6. Shibayama K, Watanabe H, Tabata M, Sasaki S, Takanashi S, Sumiyoshi T, et al. Impact of ejection fraction on long-term outcome after elective aortic valve replacement in octogenarians with aortic stenosis. Circ J 2012; 76: 1761–1767. 9. Bonow RO, Carabello B, Chatterjee K, Otto CM, Shah PM, Shanewise JS, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1988 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2006; 114: 450–527. 3. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290–3295. 29. Perera S, Wijesinghe N, Ly E, Devlin G, Pasupati S. Outcomes of patients with untreated severe aortic stenosis in real-world practice. NZ Med J 2011; 124: 40–48. 27. Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980; 99: 419–424. 28. Bouma B, van den Brink RB, van der Meulen JH, Verheul HM, Cheriex EC, Hamer HM, et al. To operate or not on elderly patients with aortic stenosis: The decision and its consequences. Heart 1999; 82: 143–148. 22. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H; on behalf of the CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 study. Circ J 2011; 75: 823–833. 5. Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, et al. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J 2014; 78: 1083–1090. 19. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725–732. 30. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Piérard L, et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation 2009; 120: 69–75. 21. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, et al. Predicting survival in heart failure: A risk score based on 39372 patients from 30 studies. Eur Heart J 2013; 34: 1404–1413. 11. Japanese Circulation Society. Guidelines for Surgical and Interventional Treatment of Valvular Heart Disease (JCS2012). Available at: www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf (in Japanese) (accessed April 20, 2015). 2. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38(Suppl 1): 61–67. 12. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvulo-arterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol 2009; 54: 1003–1011. 15. Bahlmann E, Cramariuc D, Gerdts E, Gohlke-Baerwolf C, Nienaber CA, Eriksen E, et al. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: A SEAS substudy. JACC Cardiovasc Imaging 2010; 3: 555–562. 17. Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AH, et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail 2012; 5: 183–190. 25. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240–e327, doi:10.1161/CIR.0b013e31829e8776. 8. Henkel DM, Malouf JF, Connolly HA, Michelena HI, Scott CG, Pellikka PA, et al. Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: Characteristics and outcomes. J Am Coll Cardiol 2012; 60: 2325–2329. 10. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS),Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451–2496. 13. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 2000; 100: 765–771. 14. Kume T, Okura H, Kawamoto T, Watanabe N, Hayashida A, Yoshida K, et al. Clinical implication of energy loss coefficient in patients with severe aortic stenosis diagnosed by Doppler echocardiography. Circ J 2008; 72: 1265–1269. 26. World Health Organization. Nutritional anemias: Report of a WHO scientific group. WHO Tech Rep Ser 1968; 405: 3–37. 1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet 2006; 368: 1005–1011. 7. Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010; 121: 1502–1509. 26040295 - Circ J. 2015;79(7):1458-9 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – ident: 8 doi: 10.1016/j.jacc.2012.08.988 – ident: 25 doi: 10.1161/CIR.0b013e31829e8776 – ident: 12 doi: 10.1016/j.jacc.2009.04.079 – ident: 13 doi: 10.1161/01.CIR.101.7.765 – ident: 10 – ident: 22 doi: 10.1253/circj.CJ-11-0135 – ident: 30 doi: 10.1161/CIRCULATIONAHA.108.808857 – ident: 1 doi: 10.1016/S0140-6736(06)69208-8 – ident: 18 doi: 10.1016/j.amjcard.2004.05.055 – ident: 20 doi: 10.1161/CIRCULATIONAHA.105.584102 – ident: 6 doi: 10.1253/circj.CJ-12-0025 – ident: 15 doi: 10.1016/j.jcmg.2009.11.019 – ident: 2 doi: 10.1161/01.CIR.38.1S5.V-61 – ident: 31 doi: 10.1016/0735-1097(90)90234-G – ident: 26 – ident: 7 doi: 10.1161/CIRCULATIONAHA.109.909903 – ident: 9 doi: 10.1016/j.jacc.2006.05.021 – ident: 14 doi: 10.1253/circj.72.1265 – ident: 19 doi: 10.1067/mhj.2001.117131 – ident: 34 doi: 10.1016/j.jtcvs.2007.08.058 – ident: 23 doi: 10.1253/circj.CJ-13-0127 – ident: 11 – ident: 17 doi: 10.1161/CIRCHEARTFAILURE.111.965020 – ident: 28 doi: 10.1136/hrt.82.2.143 – ident: 21 doi: 10.1093/eurheartj/ehs337 – ident: 27 doi: 10.1016/0002-8703(80)90375-0 – ident: 32 doi: 10.1056/NEJM200008313430903 – ident: 29 – ident: 33 doi: 10.1253/circj.CJ-11-0012 – ident: 24 doi: 10.1253/circj.CJ-13-1009 – ident: 4 doi: 10.1016/j.athoracsur.2006.07.048 – ident: 16 doi: 10.1016/j.amjcard.2012.10.015 – ident: 3 doi: 10.1161/CIRCULATIONAHA.104.495903 – ident: 5 doi: 10.1253/circj.CJ-14-0162 |
SSID | ssj0029059 |
Score | 2.1563864 |
Snippet | Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed... The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities. We aimed to develop a risk score for... BACKGROUNDThe risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.METHODS AND RESULTSWe aimed to... |
SourceID | proquest crossref pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1631 |
SubjectTerms | Age Factors Aged Aged, 80 and over Aortic stenosis Aortic Valve Stenosis - mortality Aortic Valve Stenosis - physiopathology Asian Continental Ancestry Group Female Follow-Up Studies Heart failure Humans Japan - epidemiology Male Proportional Hazards Models Prospective Studies Risk Assessment Risk score Sex Factors |
Title | Comprehensive Risk Stratification of Japanese Patients With Aortic Stenosis – A Proposal of a New Risk Score From the CHART-2 Study |
URI | https://www.jstage.jst.go.jp/article/circj/79/7/79_CJ-15-0062/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/25947000 https://search.proquest.com/docview/1692294242 |
Volume | 79 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Circulation Journal, 2015/06/25, Vol.79(7), pp.1631-1638 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRAviOsoNxmJF4Q8GjupkydUdZ1KWYfEOjGeIsdxaDqpmZrlD_DLOSd2khYxaTzwElWOfdrmfLG_Y58LIe8CE3pSyYwFaZIxPxARi8D6YUOtpUnhhsnwRHd6Jk8vwqOJP-n1muqtXdt_1TS0ga4xcvYftN0KhQb4DDqHK2gdrrfSO77gG7N0funf0HO8zkCLLkEtPZzBEomlJzFDf17HuH3H_dhRgfLQ82tdlHnJ2AgDCa6K0jJWVXtDWpGY_RJYr4tNGU-BFzNeeyXunBOP8412BcLaJBU3Za5AQe0P2x7oPEvbzSBVl37CkKJVvim65ktlqfAPVVbL_LK9M8-ruprSh7kq1bpIqm67IlW2bPdZketlI8xtgtgA0ENjp2zhS-aHfLA9p9sCNQ67cmuCBvrpbS32yEb_upDwuhqIhv-6OhzPmBcwjDbtFs3GUeD0a3x8fnISLyYXiz1yh8N0h3U0jj5_ac3-CBisOyAHqR__lLlDiO6uwCb4aW42d2ras3hIHjh7hY4s0B6Rnlk_JvfmziPjCfm1gzeK4KC7eKNFRhu10gZvFPFGLd7oFt5ogzccpSjgzYlEvFHEGwWYUIc3WuPtKTk_nizGU-bqejDtR_41G3o6zYzODBdJKrSnBxE3nEuegm0O5muYGRUNhqFQUgE9HnpKKJ2lsDZDH8GFeEb218XaPCc0xFPszOeJ5yW-NCaJPEzymfLUCJEIv0_eNw83vrLpW2I0e0ERca2IeDyLvSBGRfTJJ_v0257uJXY9ZRRLvHQjug5LtYHJp0_eNmqLYZbGozd4uEVVxt4w4jzygQ_3yYHVZ_stPIh8CczkxS1GvyT3Ef52D_AV2b_eVOY12SvT6k0Nut9TZsEL |
link.rule.ids | 315,782,786,4028,27932,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+Risk+Stratification+of+Japanese+Patients+With+Aortic+Stenosis--A+Proposal+of+a+New+Risk+Score+From+the+CHART-2+Study&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Sato%2C+Kenjiro&rft.au=Sakata%2C+Yasuhiko&rft.au=Miura%2C+Masanobu&rft.au=Tadaki%2C+Soichiro&rft.date=2015&rft.eissn=1347-4820&rft.volume=79&rft.issue=7&rft.spage=1631&rft.epage=1638&rft_id=info:doi/10.1253%2Fcircj.CJ-15-0062&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon |